Xiao-Mei Ge

Salvianic acid A alleviates hepatic fibrosis by inhibiting the AKT1/NF-κB axis.

Hepatic fibrosis (HF) is a crucial and reversible stage, yet there is a paucity of effective clinical antifibrotic drugs. Salvianic acid A (SAA) has shown antifibrotic potential in preliminary studies; however, its molecular mechanisms and potential targets remain incompletely understood. To evaluate the therapeutic ef...